selected publications

• letter

  • Is «Joker» Syndrome a Distinctive Characteristic of Neuro-Behçet's Disease [¿Síndrome del Guasón, característica distintiva de neuro-Behçet?].  Reumatologia Clinica. 368-369. 2021-01-01
  • International engagement by United States academic neurology departments: A national survey.  Annals of Neurology. 150-152. 2015-01-01

• article

  • Facial pain associated with vein of Trolard thrombosis Case report Neurology.  BMJ Case Reports.  16:-. 2023-01-01
  • Galcanezumab for the preventive treatment of episodic and chronic migraine in real life: A prospective multicenter study in Colombia and Mexico including effects on anxiety and depression - On behalf of ASOLACE.  Research Square.  :-. 2023-01-01
  • Impact of COVID-19 Pandemic Lockdown on Migraine Patients in Latin America.  International Journal of Environmental Research and Public Health.  20:3598-. 2023-01-01
  • Neurocysticercosis and epilepsy: Imaging and clinical characteristics.  Epileptic Disorders.  25:94-103. 2023-01-01
  • Characterization and classification of Parkinson's disease patients based on symbolic dynamics analysis of heart rate variability.  Biomedical Signal Processing and Control.  71:-. 2022-01-01
  • Cryptococcal meningitis due to Cryptococcus gattii in an immunocompetent patient: uncommon presentation of a thunderclap headache.  BMJ Case Reports.  15:-. 2022-01-01
  • Optic ataxia in a patient with HaNDL syndrome.  BMJ Case Reports.  15:-. 2022-01-01
  • Optic neuromyelitis after vaccination against SARS-CoV-2.  BMJ case reports.  15:-. 2022-01-01
  • Raman Spectroscopy Study of Skin Biopsies from Patients with Parkinson’s Disease: Trends in Alpha-Synuclein Aggregation from the Amide I Region.  Applied Spectroscopy.  :-. 2022-01-01
  • Unusual complication of Herpes simplex encephalitis: complete Klüver-Bucy syndrome.  BMJ Case Reports.  15:-. 2022-01-01
  • Catatonic syndrome as the presentation of encephalitis in association with COVID-19.  BMJ Case Reports.  14:-. 2021-01-01
  • Characterization and classification of Parkinson's disease patients based on symbolic dynamics analysis of heart rate variability.  Biomedical Signal Processing and Control.  71:1-11-. 2021-01-01
  • Comprehensive management of adults with chronic migraine: Clinical practice guidelines in Mexico.  Cephalalgia Reports.  4:-. 2021-01-01
  • Editorial, January 2021: COVID-19 is here. What comes next?.  Revista Mexicana de Neurociencia.  22:1-2-. 2021-01-01
  • Hoping for a better future.  Revista Mexicana de Neurociencia.  22:218-218-. 2021-01-01
  • Neurological disease and behavioral changes in the human being.  Revista Mexicana de Neurociencia.  22:132-133-. 2021-01-01
  • Virus, Immunity and Human Neurodegenerative Diseases. A Perspective.  Acta Scientific Microbiology.  4:34-36-. 2021-01-01
  • A novel disposable sensor for measure intra-abdominal pressure [Nuevo sensor desechable para medir la presión intraabdominal].  Cirugia y Cirujanos (English Edition).  88:7-14. 2020-01-01
  • Analysis of vibrational modes from alpha-synuclein: a theoretical model using density functional theory and Raman spectroscopy.  Health and Technology.  10:465-470. 2020-01-01
  • Dosing Recommendations Based on Population Pharmacokinetics of Lamotrigine in Mexican Adult Patients With Epilepsy.  Journal of Pharmaceutical Sciences.  109:2902-2908. 2020-01-01
  • Hemichorea-Hemiballism: An Uncommon Presentation of Central Nervous System Tuberculosis.  Movement Disorders Clinical Practice.  7:S77-S79. 2020-01-01
  • Parkinsonism and Rapidly Progressive Dementia Secondary to Neuro-Behçet.  Movement Disorders Clinical Practice.  7:S74-S76. 2020-01-01
  • Perinuclear lamin a and nucleoplasmic lamin B2 characterize two types of hippocampal neurons through Alzheimer’s disease progression 2020-01-01
  • Population Pharmacokinetics and Dosing Recommendations of Levetiracetam in Adult and Elderly Patients With Epilepsy.  Journal of Pharmaceutical Sciences.  109:2070-2078. 2020-01-01
  • Extended-release vinpocetine: A possible adjuvant treatment for focal onset epileptic seizures [Vinpocetina de liberación prolongada: Un posible tratamiento adyuvante en crisis epiléptica de inicio focal].  Boletin Medico del Hospital Infantil de Mexico.  76:215-224. 2019-01-01
  • Low levels of alpha-synuclein in peripheral tissues are related to clinical relapse in relapsing-remitting multiple sclerosis: a pilot cross-sectional study.  Journal of the Neurological Sciences.  396:87-93. 2019-01-01
  • Association of white matter diffusion characteristics and cognitive deficits in temporal lobe epilepsy.  Epilepsy and Behavior.  79:138-145. 2018-01-01
  • EpiNet as a way of involving more physicians and patients in epilepsy research: Validation study and accreditation process.  Epilepsia Open.  2:20-31. 2017-01-01
  • Oxidative stress modifies the levels and phosphorylation state of tau protein in human fibroblasts.  Frontiers in Neuroscience.  11:-. 2017-01-01
  • Tau protein in oral mucosa and cognitive state: A cross-sectional study.  Frontiers in Neurology.  8:-. 2017-01-01
  • The Presence of Alpha-Synuclein in Skin from Melanoma and Patients with Parkinson's Disease.  Movement Disorders Clinical Practice.  4:724-732. 2017-01-01
  • Usefulness of Ilae 2010 classification in Mexican epilepsy patients.  Journal of the Neurological Sciences.  376:13-15. 2017-01-01
  • Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry.  Journal of the American Heart Association.  5:-. 2016-01-01
  • Epileptic crises and the choice of appropriate pharmacological therapy [Crisis epilépticas y selección de la terapia farmacológica adecuada].  Salud(i)Ciencia.  22:264-266. 2016-01-01
  • Parkinson disease and progressive supranuclear palsy: Protein expression in skin.  Annals of Clinical and Translational Neurology.  3:191-199. 2016-01-01
  • Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: A randomized controlled trial.  Acta Neurologica Scandinavica.  129:143-153. 2014-01-01
  • Meningeal coccidioidomycosis: Case report and literature review [Coccidioidomicosis meníngea: Reporte de caso y revisión de la literatura].  Revista Mexicana de Neurociencia.  15:224-228. 2014-01-01
  • α-Synuclein inclusions in the skin of Parkinson's disease and parkinsonism.  Annals of Clinical and Translational Neurology.  1:471-478. 2014-01-01
  • Typographic legibility factors associated with reading epilepsy [Factores de legibilidad tipográfica asociados con epilepsia de la lectura].  Revista Mexicana de Neurociencia.  14:68-75. 2013-01-01
  • Delta-sarcoglycanopathy: Case report and review of literature [Delta-sarcoglicanopatía: Reporte de un caso y revisión de la literatura].  Revista Mexicana de Neurociencia.  12:-. 2011-01-01
  • Risk factors, causes, and outcome in stroke types in Mexico. The RENAMEVASC Study [Factores de riesgo, causas y pronóstico de los tipos de enfermedad vascular cerebral en México: Estudio RENAMEVASC].  Revista Mexicana de Neurociencia.  12:224-234. 2011-01-01
  • Assessment of atherothrombosis and its treatment in Mexico: First-year data of the REACH registry.  Clinical Cardiology.  33:445-451. 2010-01-01
  • Evaluation of changes in the treatment of spontaneous intracerebral haemorrhage in a regional hospital in Mexico [Evaluación de cambios en el tratamiento de la hemorragia intracerebral espontánea en un hospital regional mexicano].  Revista de Neurologia.  50:201-206. 2010-01-01
  • Paraoxonase gene mutations in amyotrophic lateral sclerosis.  Annals of Neurology.  68:102-107. 2010-01-01
  • Topiramate vs. Amitriptyline in prophylactic treatment of migraine: A controlled clinical trial.  Revista Mexicana de Neurociencia.  11:338-342. 2010-01-01
  • Population pharmacokinetics of carbamazepine in epileptic children [Farmacocinética poblacional de carbamazepina en niños epilépticos].  Revista Mexicana de Ciencias Farmaceuticas.  40:19-27. 2009-01-01
  • Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.  Proceedings of the National Academy of Sciences of the United States of America.  106:9004-9009. 2009-01-01
  • Use of statins for the treatment of spontaneous intracerebral hemorrhage: Results of a pilot study.  Zentralblatt fur Neurochirurgie.  70:15-20. 2009-01-01
  • A clinical-epidemiological approximation to intracerebral hemorrhage in a Mexican hospital: Analysis of factors associated to mortality [Aproximación clinicoepidemiológica de la hemorragia intracerebral en un hospital mexicano: Análisis de factores asociados a la mortalidad].  Revista de Neurologia.  46:67-72. 2008-01-01
  • A common haplotype within the PON1 promoter region is associated with sporadic ALS.  Amyotrophic Lateral Sclerosis.  9:306-314. 2008-01-01
  • New VAPB deletion variant and exclusion of VAPB mutations in familial ALS.  Neurology.  70:1179-1185. 2008-01-01
  • Population pharmacokinetics of valproate in Mexican children with epilepsy.  Biopharmaceutics and Drug Disposition.  29:511-520. 2008-01-01
  • Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.  Epilepsy Research.  74:60-69. 2007-01-01
  • Short-term prognnosis of transient ischemic attacks. Mexican multicenter stroke registry [Pronóstico a corto plazo de la isquemia cerebral transitoria. Registro multicéntrico de enfermedad vascular cerebral en México] 2006-01-01
  • Population pharmacokinetics of carbamazepine in adults with epilepsy [Farmacocinética poblacional de carbamacepina en pacientes epilépticos adultos] 2005-01-01
  • Effect of vigabatrin on the pharmacokinetics of carbamazepine.  Journal of Clinical Pharmacy and Therapeutics.  27:427-430. 2002-01-01
  • Exposure to arsenic and lead and neuropsychological development in Mexican children.  Environmental Research.  85:69-76. 2001-01-01
  • Neurocysticercosis in a general hospital in San Luis Potosí, México [Neurocisticercosis en un hospital general en San Luis Potosí, México].  Revista Ecuatoriana de Neurologia.  9:33-35. 2000-01-01
  • Valproic acid clearance in children with epilepsy.  Journal of Clinical Pharmacy and Therapeutics.  23:31-34. 1998-01-01
  • Plasma concentrations of vigabatrin in epileptic patients.  Journal of Clinical Pharmacy and Therapeutics.  21:393-398. 1996-01-01
  • Magnetic resonance in epilepsy [RESONANCIA MAGNETICA EN EPILEPSIA].  Revista Ecuatoriana de Neurologia.  4:43-46. 1995-01-01

• chapter

  • ALS Policy in Mexico.  Palgrave Macmillan, Singapore. 191-199. 2021-01-01
  • Neurocysticercosis: Are the Criteria Diagnostic Enough?.  Highlights on Medicine and Medical Research . 104-106. 2021-01-01
  • Hereditary Spastic Paraplegia.  International Neurology: A Clinical Approach. 205-207. 2010-01-01

• conference paper

  • Compare complications during hospitalization between patients with and without dysphagia following acute stroke.  Neurology. -. 2023-01-01
  • International case control study of Sudden Unexpected Death in Epilepsy (SUDEP).  Epilepsia. 68-68-. 2021-01-01
  • Fluorescence background removal method for biological Raman spectroscopy based on empirical mode decomposition.  Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS. 3610-3613. 2016-01-01
• Skin biomarkers for neurodegenerative disease: a future perspective.  Neurodegenerative disease management.  5:465-467. 2015-01-01
• Spinal arteriovenous malformations.  Revista Mexicana de Neurociencia. 77-84. 2021-01-01
• Late onset adrenoleukodystrophy: A review related clinical case report.  eNeurologicalSci. 62-67. 2019-01-01
• [Diagnosis and treatment of Pompe disease]. [Diagnóstico y tratamiento en la enfermedad de Pompe.].  Revista médica del Instituto Mexicano del Seguro Social. 536-551. 2013-01-01
• Statesmen with epilepsy [Estadistas con epilepsia].  Revista Mexicana de Neurociencia. 36-55. 2012-01-01
• Rational pharmacotherapy in epilepsy [Farmacoterapia racional en epilepsia].  Revista Mexicana de Neurociencia. 87-94. 2011-01-01
• Statins and brain protection mechanisms [Estatinas y mecanismos de protección cerebral].  Revista de Neurologia. 359-364. 2007-01-01